Cargando…

Response to Comment on: Harrison et al. β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy. Diabetes Care 2012;35:1406–1412

Detalles Bibliográficos
Autores principales: Harrison, Lindsay B., Raskin, Philip, Lingvay, Ildiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526226/
https://www.ncbi.nlm.nih.gov/pubmed/23264300
http://dx.doi.org/10.2337/dc12-1659
_version_ 1782253523298156544
author Harrison, Lindsay B.
Raskin, Philip
Lingvay, Ildiko
author_facet Harrison, Lindsay B.
Raskin, Philip
Lingvay, Ildiko
author_sort Harrison, Lindsay B.
collection PubMed
description
format Online
Article
Text
id pubmed-3526226
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-35262262014-01-01 Response to Comment on: Harrison et al. β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy. Diabetes Care 2012;35:1406–1412 Harrison, Lindsay B. Raskin, Philip Lingvay, Ildiko Diabetes Care Online Letters: Comments and Responses American Diabetes Association 2013-01 2012-12-11 /pmc/articles/PMC3526226/ /pubmed/23264300 http://dx.doi.org/10.2337/dc12-1659 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Online Letters: Comments and Responses
Harrison, Lindsay B.
Raskin, Philip
Lingvay, Ildiko
Response to Comment on: Harrison et al. β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy. Diabetes Care 2012;35:1406–1412
title Response to Comment on: Harrison et al. β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy. Diabetes Care 2012;35:1406–1412
title_full Response to Comment on: Harrison et al. β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy. Diabetes Care 2012;35:1406–1412
title_fullStr Response to Comment on: Harrison et al. β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy. Diabetes Care 2012;35:1406–1412
title_full_unstemmed Response to Comment on: Harrison et al. β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy. Diabetes Care 2012;35:1406–1412
title_short Response to Comment on: Harrison et al. β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy. Diabetes Care 2012;35:1406–1412
title_sort response to comment on: harrison et al. β-cell function preservation after 3.5 years of intensive diabetes therapy. diabetes care 2012;35:1406–1412
topic Online Letters: Comments and Responses
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526226/
https://www.ncbi.nlm.nih.gov/pubmed/23264300
http://dx.doi.org/10.2337/dc12-1659
work_keys_str_mv AT harrisonlindsayb responsetocommentonharrisonetalbcellfunctionpreservationafter35yearsofintensivediabetestherapydiabetescare20123514061412
AT raskinphilip responsetocommentonharrisonetalbcellfunctionpreservationafter35yearsofintensivediabetestherapydiabetescare20123514061412
AT lingvayildiko responsetocommentonharrisonetalbcellfunctionpreservationafter35yearsofintensivediabetestherapydiabetescare20123514061412